GENE ONLINE|News &
Opinion
Blog

Oncology
China’s BeiGene to Build a Biologics Manufacturing Site in the US
2021-08-04
Innovent, Lilly Bag Third Approval for PD-1 Inhibitor Tyvyt in China
2021-06-07
Screening for a brighter future: NHS Oncology Virtual Conference
2021-05-28
BMS Wins Agenus’ anti-TIGIT Asset to Bolster I-O Pipeline
2021-05-21
Illumina Looks to Consolidate NGS Market in APAC Region, Collaborates with Geneseeq to Develop IVD Kits in China
2021-03-21
After Five Year Oncology Alliance, Takeda Acquires Maverick to Embark on Solid Tumor Quest
2021-03-10
AstraZeneca Voluntarily Withdraws Checkpoint Inhibitor Approved for Bladder Cancer Indication
2021-02-25
BITT’s TNFR2 Antagonist to Enter Clinical Trials In Collaboration with BeiGene
2021-02-20
BIOCEO21: Scientists and Investors Weigh on Pioneering Innovations and Investments in Oncology
2021-02-18
Key Takeaways from the JPM Healthcare Conference: Gilead, Regeneron Lay Oncology Plans, Merck Looks Beyond Keytruda
2021-01-17
Investors Bet $120 Million on Ikena Oncology’s Cancer Therapies
2021-01-06
Boehringer Ingelheim’s Newest Acquisition Reinforces its Focus on Immuno-Oncology
2020-12-14
D3 Bio Launches with $200 Million to Advance Precision Medicine in Oncology and Immunology Space
2020-11-22
Scorpion Therapeutics Scores $108 Million Series A Funding for Oncological Research
2020-10-28
Pfizer Strengthens Immuno-Oncology Portfolio with $200 Million Investment in Chinese Startup
2020-10-03
1 2 3 4 5 6
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top